Covalon Technologies Ltd
XTSX:COV

Watchlist Manager
Covalon Technologies Ltd Logo
Covalon Technologies Ltd
XTSX:COV
Watchlist
Price: 3.55 CAD -2.2% Market Closed
Market Cap: 97.3m CAD
Have any thoughts about
Covalon Technologies Ltd?
Write Note

Covalon Technologies Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Covalon Technologies Ltd
Total Equity Peer Comparison

Comparables:
B
DRUG
TH
RPTX
AUPH
EDT

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Covalon Technologies Ltd
XTSX:COV
Total Equity
CA$21.7m
CAGR 3-Years
34%
CAGR 5-Years
16%
CAGR 10-Years
13%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Total Equity
CA$19.4m
CAGR 3-Years
199%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Total Equity
-$19.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Total Equity
$212.1m
CAGR 3-Years
-10%
CAGR 5-Years
86%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Total Equity
$364.6m
CAGR 3-Years
3%
CAGR 5-Years
24%
CAGR 10-Years
22%
Spectral Medical Inc
TSX:EDT
Total Equity
-CA$22.8m
CAGR 3-Years
-265%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Covalon Technologies Ltd's Total Equity?
Total Equity
21.7m CAD

Based on the financial report for Jun 30, 2024, Covalon Technologies Ltd's Total Equity amounts to 21.7m CAD.

What is Covalon Technologies Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
13%

Over the last year, the Total Equity growth was 3%. The average annual Total Equity growth rates for Covalon Technologies Ltd have been 34% over the past three years , 16% over the past five years , and 13% over the past ten years .

Back to Top